Professor of Surgery Cleveland Clinic Lerner College of Medicine
Urology
Dr. Stuart M. Flechner, MD
|
|
Give Review
Dr. Stuart M. Flechner is an expert in the field of Urology. He went to David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a one of the best medicals schools. David Geffen School of Medicine at UCLA is ranked 13/7 in Research/PrimaryCare. He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Dr. Stuart M. Flechner is a published doctor and has 43 publications published. The lastest was: 'Association between Kidney Transplant Center Performance and the Survival Benefit of Transplantation Versus Dialysis.' He accepts Medicare.
Publications
- Association between Kidney Transplant Center Performance and the Survival Benefit of Transplantation Versus Dialysis.
- The Pharmacokinetics and Pharmacodynamics of TOL101, a MUrine IgM Anti-Human αβ T Cell Receptor Antibody, in Renal Transplant Patients.
- Molecular Classifiers for Acute Kidney Transplant Rejection in Peripheral Blood by Whole Genome Gene Expression Profiling.
- Transient versus Persistent BK Viremia and Long-Term Outcomes after Kidney and Kidney-Pancreas Transplantation.
- Stone Disease in Living-Related Renal Donors: Long-Term Outcomes for Transplant Donors and Recipients.
- CMV Viremia Is Associated With a Decreased Incidence of BKV Reactivation after Kidney and Kidney-Pancreas Transplantation.
- The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in Kidney transplantation.
- A randomized, open-label study of sirolimus versus cyclosporine in primary de novo Renal allograft recipients.
- The impact of deceased donor Kidney risk significantly varies by recipient characteristics.
- Contrasting patterns of viral load response in transplant recipients with BK polyomaVirus DNAemia on leflunomide therapy.
- The association of center performance evaluations and Kidney transplant volume in the United States.
- Case-matched comparison of perioperative outcomes after surgical treatment of sigmoid diverticulitis in solid organ transplant recipients versus immunocompetent patients.
- Renal allograft capsular repair surgical technique to reduce allograft discard rates of Kidneys with capsular injury.
- Renal autotransplantation and modified pyelovesicostomy for intractable metabolic stone disease.
- Patient Participation in Research Among Solid Organ Transplant Recipients in the United States.
- Combined Liver-Kidney Transplants: Allosensitization and Recipient Outcomes.
- Can the nephron be spared?
- The role of proteasome inhibition with bortezomib in the treatment of antibody-mediated rejection after Kidney-only or Kidney-combined organ transplantation.
- Glomerular filtration rate slopes have significantly improved among Renal transplants in the United States.
- Hidden selection bias deriving from donor organ characteristics does not affect performance evaluations of Kidney transplant centers.
- An emerging population: Kidney transplant candidates who are placed on the waiting list after liver, heart, and lung transplantation.
- Re: Hajj et al. Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and Chronic renal failure (Urology 2010;74:631-634).
- Deconvoluting post-transplant immunity: cell subset-Specific mapping reveals pathways for activation and expansion of memory T, monocytes and B cells.
- Management of the adRenal gland during partial nephrectomy.
- Sirolimus in Kidney transplantation indications and practical guidelines: de novo sirolimus-based therapy without calcineurin inhibitors.
- A systematic approach to minimizing wound problems for de novo sirolimus-treated Kidney transplant recipients.
- Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral Blood.
- Evaluation of Renal function in transplantation.
- Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhib...
- Differences in proteinuria and graft function in de novo sirolimus-based vs. calcineurin inhibitor-based immunosuppression in live donor Kidney transplantation.
- Posttransplant diabetes mellitus in Kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs.
- Laparoscopic donor nephrectomy gene expression profiling reveals upregulation of stress and ischemia associated genes compared to control Kidneys.
- Simultaneous vs. sequential laparoscopic bilateral native nephrectomy and Renal transplantation.
- Current management of transplant Renal artery stenosis: clinical utility of duplex Doppler ultrasonography.
- Laparoscopic live donor nephrectomy has equivalent early and late Renal function outcomes compared with open donor nephrectomy.
- The effect of 2-gram versus 1-gram concentration controlled mycophenolate mofetil on Renal transplant outcomes using sirolimus-based calcineurin inhibitor drug-free im...
- Fate of donor Kidney: laparoscopic versus open technique.
- Salvage of compromised renal vessels in Kidney transplantation using third-party cadaveric extenders: impact on posttransplant anti-HLA antibody formation.
- The influence of various maintenance immunosuppressive drugs on lymphocele formation and treatment after Kidney transplantation.
- The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 Kidney-transplant recipients.
- Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine.
- Will you still list me when I'm 64? Apologies to Lennon and McCartney.
Procedures Preformed
- AdRenalectomy
- Cystometry
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- Kidney and Ureter Removal
- View All
Conditions Treated
- Bladder Atony
- Bladder Cancer
- Bladder Infection
- Blood in Urine (Hematuria)
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
Cleveland Clinic Foundation -
UCSF -
David Geffen School of Medicine at UCLA
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1487680807 | |
| NPPES Provider LastName | FLECHNER | |
| NPPES Provider FirstName | STUART | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | Urology | |
| Total Claim Count | 930.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1487680807 |
| Last Name Of The Provider | FLECHNER |
| First Name Of The Provider | STUART |
| View All |
Similar Doctors
|
|
Dr. Sandip P. Vasavada, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Tim A. Sidor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Reid M. Morse, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Drogo Karl Montague, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raymond R. Rackley, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Daniel J. Greene, MD |
|
|
Dr. Catherine M. Seager, MD |